Isomorphic Labs
PVT · PVT·London, United Kingdom·Private·Preclinical
Alphabet-backed AI drug discovery company founded by Demis Hassabis, leveraging its proprietary Isomorphic Drug Design Engine (an evolution of AlphaFold 3) to computationally design novel small molecules against previously undruggable targets. Funded with $600M and nearly $3B in combined partnership deals with Eli Lilly and Novartis.
Decks (1)
| Title | Occasion | Date | Slides | Source |
|---|---|---|---|---|
| Isomorphic Labs website | Website | May 6, 2026 | 3 |